Blueprint Medicines Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09627Y1091
USD
129.46
0.18 (0.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
508.82
249.38
204.04
180.08
793.74
66.51
44.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
508.82
249.38
204.04
180.08
793.74
66.51
44.52
Raw Material Cost
36.45
24.46
46.86
38.52
12.78
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
68.81
51.60
16.77
0.00
0.00
0.00
0.07
Selling and Distribution Expenses
359.27
295.14
229.01
188.99
151.95
86.14
43.68
Other Expenses
25.63
36.45
44.89
59.46
32.03
33.15
24.35
Total Expenditure (Excl Depreciation)
720.87
735.66
741.55
822.06
485.03
417.59
287.30
Operating Profit (PBDIT) excl Other Income
-212
-486.3
-537.5
-642
308.7
-351.1
-242.8
Other Income
41.31
31.87
2.00
0.90
6.23
13.63
10.46
Operating Profit (PBDIT)
-154.44
-442.75
-515.41
-628.30
327.29
-337.44
-232.32
Interest
68.81
51.60
16.77
0.00
0.00
0.00
0.07
Exceptional Items
173.68
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
472.37
224.92
157.18
141.56
780.96
0.00
0.00
Depreciation
16.29
11.66
20.10
12.79
12.35
10.25
4.25
Profit Before Tax
-65.86
-506.02
-552.28
-641.08
314.94
-347.69
-236.64
Tax
1.23
0.97
5.24
3.00
1.06
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-67.09
-506.98
-557.52
-644.09
313.88
-347.69
-236.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-67.09
-506.98
-557.52
-644.09
313.88
-347.69
-236.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-67.09
-506.98
-557.52
-644.09
313.88
-347.69
-236.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
298.67
130.61
514.68
970.74
1,470.09
464.36
419.01
Earnings per share (EPS)
-1.07
-8.37
-9.35
-11.01
5.59
-7.27
-5.39
Diluted Earnings per share
-1.07
-8.37
-9.35
-11.01
5.59
-7.27
-5.39
Operating Profit Margin (Excl OI)
-41.67%
-194.99%
-263.44%
-356.5%
38.89%
-543.25%
-554.86%
Gross Profit Margin
-9.74%
-198.23%
-260.83%
-348.9%
41.23%
-507.34%
-521.99%
PAT Margin
-13.19%
-203.3%
-273.24%
-357.67%
39.54%
-522.75%
-531.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 104.01% vs 22.25% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 86.77% vs 9.06% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 58.74% vs 8.27% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 33.33% vs 207.14% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Blueprint Medicines Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
508.82
290.51
218.31
75.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
508.82
290.51
218.31
75.15%
Raw Material Cost
36.45
26.81
9.64
35.96%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
68.81
0.00
68.81
Selling and Distribution Expenses
359.27
106.94
252.33
235.95%
Other Expenses
25.63
5.36
20.27
378.17%
Total Expenditure (Excl Depreciation)
720.87
187.32
533.55
284.83%
Operating Profit (PBDIT) excl Other Income
-212.04
103.19
-315.23
-305.49%
Other Income
41.31
29.66
11.65
39.28%
Operating Profit (PBDIT)
-154.44
139.60
-294.04
-210.63%
Interest
68.81
0.00
68.81
Exceptional Items
173.68
-37.50
211.18
563.15%
Gross Profit (PBDT)
472.37
263.71
208.66
79.12%
Depreciation
16.29
6.75
9.54
141.33%
Profit Before Tax
-65.86
95.36
-161.22
-169.06%
Tax
1.23
6.20
-4.97
-80.16%
Provisions and contingencies
0
0
0.00
Profit After Tax
-67.09
89.16
-156.25
-175.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-67.09
89.16
-156.25
-175.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-67.09
89.16
-156.25
-175.25%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
298.67
946.38
-647.71
-68.44%
Earnings per share (EPS)
-1.07
3.00
-4.07
-135.67%
Diluted Earnings per share
-1.07
3.00
-4.07
-135.67%
Operating Profit Margin (Excl OI)
-41.67%
35.52%
0.00
-77.19%
Gross Profit Margin
-9.74%
35.15%
0.00
-44.89%
PAT Margin
-13.19%
30.69%
0.00
-43.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 50.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 104.01% vs 22.25% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -6.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 86.77% vs 9.06% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -19.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 58.74% vs 8.27% in Dec 2023

Annual - Interest
Interest 6.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 33.33% vs 207.14% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -41.67%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023